Researchers begin clinical trials to investigate blood thinning as a coronovirus treatment

American researchers have launched two clinical trials investigating the use of blood thinners to treat COVID-19, the National Institutes of Health (NIOS) Announced Thursday.

One study will focus on those who were hospitalized for COVID-19 and the other will focus on those who were infected, but not hospitalized.

Are funded through studies President TrumpDonald John TrumpCoin: ‘I guarantee it’s not going to go well’ Pompeo, who founded the Woodward interview, says ‘enough chance’ Navalny’s poison was ordered by senior Russian official Trump, he says He will almost certainly read the ‘Woodward Book’.“Operation Warp Speed”, which seeks to accelerate COVID-19 treatment and vaccines.

A third study that will begin at a later date will test blood thinners on those who have recovered and no longer test positive for coronovirus to see if it develops blood clots after recovery. Affects their chances of.

NIH officials told reporters in a conference call on Thursday that they anticipated the study to be completed within “months, not years”. Bloomberg reported.

According to the NIH, doctors have used anticoagulants in various ways to use the drug, but the study gives them “a clear sense of what the most beneficial method is”.

“There is no standard for anticoagulation in hospitalized COVID-19 patients, and a strict requirement for clinical evidence,” NIH Director Francis Collins said in a statement. “Conducting tests using many existing networks of research sites provides the scale and speed that will give us the answer faster.”